Both JQ1 and I-BET151 were small molecule inhibitors for BET proteins and JQ1 was demonstrated to attenuate inflammation and bone destruction in experimental periodontitis via neutralizing BRD4 enrichment at NF-κB, TNF-α, c-Fos, and NFATc1 [40]. Here, NFATC1 is linked to periodontitis.